Trends in Parasitology
A blueprint for success: integration of neglected tropical disease control programmes
Section snippets
Helminth infections
Lymphatic filariasis (LF), schistosomiasis and soil-transmitted helminthiasis (STH, which includes ascariasis, trichuriasis and hookworm diseases) are caused by infections with helminths (parasitic worms, including nematodes and trematodes) and remain among the most prevalent parasitic diseases in the world 1, 2, 3. Hundreds of millions of people are currently infected and thousands of millions are at risk (Table 1) 1, 3, 4, 5, 6, 7, 8. The diseases cause untold morbidity, with the poor
Lymphatic filariasis
In 1993, the International Task Force for Disease Eradication declared LF an eliminable infectious disease [19], and in 1997 the World Health Assembly (WHA) endorsed the elimination of LF as a public health problem by 2020. Subsequently, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) and a worldwide coalition (the Global Alliance to Eliminate Lymphatic Filariasis) were established and, in 2000, large-scale operations were launched, catalysed by a grant from the Bill and Melinda
Schistosomiasis
The discovery that praziquantel was a safe and effective drug against all human schistosome species was a major breakthrough for treatment of infected people and for community-based control approaches [37]. Indeed, praziquantel became the essential tool that led to the shift in the global control strategy – from transmission containment to morbidity control – that occurred in the mid-1980s [38]. Added to this, a dramatic (>90%) reduction in price of praziquantel has occurred since 1990 and many
Soil-transmitted helminthiasis
Hookworm (Ancylostoma duodenale and Necator americanus), Ascaris lumbricoides and Trichuris trichiura are the most common intestinal (soil-transmitted) nematodes 8, 10, 48. Infections have been associated with low birth weight, maintenance of malnutrition and impaired physical and cognitive development in early childhood, poor school performance, reduced work capacity and complication of pregnancy and birth outcome 34, 36. Moreover, hookworm infections are increasingly recognized as one of the
Integrating different control programmes
The LF and schistosomiasis/STH control programmes are functioning well as separate entities and each has demonstrated measurable health benefits. However, funding constraints and remaining operational challenges (e.g. reaching remote communities) have prevented some countries from implementing programmes in all areas in need of MDA. For example, to date, less than a third of the 80 LF-endemic countries have achieved a coverage exceeding 70% of at-risk populations for LF [23]. Similarly, only
Challenges at the operational level
As new efforts are initiated to integrate programmes for NTDs [11], several issues must be addressed [61]. As a first step, because of the focal distribution of several of the diseases and the paucity of spatially explicit datasets, mapping surveys to define the degree of spatial overlap of NTDs at small units of analysis (e.g. at the village or district level) are needed. Previous efforts to collate available data from the published literature to map the distribution of schistosomiasis and STH
Issues of concern
One question that could limit integrated chemotherapy is the safety of co-administered drugs. Before combination therapy with albendazole plus either ivermectin or DEC was implemented on a wide scale for LF, enhanced surveillance for adverse events was carried out in pilot studies in different epidemiological settings [68]. Although pharmacokinetic studies sponsored by WHO and the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases suggest that ivermectin
Unanswered questions
The proposal to integrate control programmes to address the huge burden of the NTDs collectively – in a first step through administration of appropriate drug packages to identified target populations – is gaining interest 11, 17. There are several unanswered questions. First, there is considerable concern that rapid expansion of the use of drugs might facilitate the development of drug resistance. Fortunately, there is no evidence to date that clinically relevant resistance has developed in
Acknowledgements
We thank the SCI team at Imperial College London and the programme collaborators in Burkina Faso, Mali, Niger, Tanzania, Uganda and Zambia. The inspiration for this article comes from our colleagues David H. Molyneux and Peter J. Hotez. A.F. is funded through the SCI by the BMGF. J.U. is indebted to Marcel Tanner, Burton H. Singer and Don de Savigny for continued and stimulating exchange and thanks the Swiss National Science Foundation for generous financial support through project no.
References (82)
Soil-transmitted helminth infections: updating the global picture
Trends Parasitol.
(2003)Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Trends Parasitol.
(2003)Mass drug treatment for lymphatic filariasis and onchocerciasis
Trends Parasitol.
(2003)Human gastrointestinal helminth infections: are they now neglected diseases?
Trends Parasitol.
(2003)New initiatives against Africa's worms
Trans. R. Soc. Trop. Med. Hyg.
(2006)Mass chemotherapy options to control lymphatic filariasis: a systematic review
Lancet Infect. Dis.
(2005)Update on immunological tests for lymphatic filariasis
Trends Parasitol.
(2004)Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment
Lancet
(2006)The role of albendazole in programmes to eliminate lymphatic filariasis
Parasitol. Today
(1999)Human hookworm infection in the 21st century
Adv. Parasitol.
(2004)
Praziquantel
Adv. Pharmacol. Chemother.
Schistosomiasis and soil-transmitted helminth infections: forging control efforts
Trans. R. Soc. Trop. Med. Hyg.
The global epidemiological situation of schistosomiasis and new approaches to control and research
Acta Trop.
The public health significance and control of schistosomiasis in China – then and now
Acta Trop.
Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda
Trans. R. Soc. Trop. Med. Hyg.
The impact of chemotherapy on morbidity due to schistosomiasis
Acta Trop.
Evaluating the epidemiological impact of national control programmes for helminths
Trends Parasitol.
Patterns in parasite epidemiology: the peak shift
Parasitol. Today
Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes
Acta Trop.
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials
Vaccine
Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area
Trans. R. Soc. Trop. Med. Hyg.
Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal
Lancet
Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria
Trans. R. Soc. Trop. Med. Hyg.
Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS)
Parasitol. Today
The ICT Filariasis Test: a rapid-format antigen test for diagnosis of bancroftian filariasis
Parasitol. Today
Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations
Trans. R. Soc. Trop. Med. Hyg.
Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review
Lancet Infect. Dis.
Mathematical modelling and the control of lymphatic filariasis
Lancet Infect. Dis.
Schistosomiasis control: keep taking the tablets
Trends Parasitol.
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
Trends Parasitol.
Effect of water resource development and management on lymphatic filariasis, and estimates of populations at risk
Am. J. Trop. Med. Hyg.
Lymphatic filariasis elimination: progress in global programme development
Ann. Trop. Med. Parasitol.
Lymphatic filariasis endemicity – an indicator of poverty?
Trop. Med. Int. Health
Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control
Expert Opin. Pharmacother.
Incorporating a rapid impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria
PLoS Med
Treatment strategies underpinning the global programme to eliminate lymphatic filariasis
Expert Opin. Pharmacother.
Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China
Southeast Asian J. Trop. Med. Public Health
Defining the cost of the Egyptian lymphatic filariasis elimination programme
Filaria J.
Soil-transmitted helminthiasis in Uganda: epidemiology and cost of control
Trop. Med. Int. Health
Cited by (157)
Monepantel is a non-competitive antagonist of nicotinic acetylcholine receptors from Ascaris suum and Oesophagostomum dentatum
2018, International Journal for Parasitology: Drugs and Drug ResistanceOpportunities for Integrated Control of Neglected Tropical Diseases That Affect the Skin
2016, Trends in ParasitologyCitation Excerpt :Several existing NTD control programs have built considerable momentum over many years and are working toward ambitious targets. It is important that integration of new programs focusing on the skin does not undermine the success of the existing programs [72]. Currently, NTD control is heavily reliant on drug donation programs, which are generally directed to specific diseases with defined public health targets and a clear ‘end-point’.
Parasitic Diseases, an Overview
2016, International Encyclopedia of Public HealthHelminthic Diseases: Schistosomiasis
2016, International Encyclopedia of Public HealthBarriers and gaps in utilization and coverage of mass drug administration program against soil-transmitted helminth infection in Bangladesh: An implementation research
2019, Journal of Infection and Public Health“Using the same hand”: The complex local perceptions of integrated one health based interventions in East Africa
2022, PLoS Neglected Tropical Diseases